Liquid profiling of circulating tumor DNA in colorectal cancer: steps needed to achieve its full clinical value as standard care

The analysis of circulating tumor DNA (ctDNA) is at the threshold of implementation into standard care for colorectal cancer (CRC) patients. However, data about the clinical utility of liquid profiling (LP), its acceptance by clinicians, and its integration into clinical workflows in real‐world sett...

Descripción completa

Detalles Bibliográficos
Autores principales: Hedtke, Maren, Pessoa Rejas, Rodrigo, Froelich, Matthias F., Ast, Volker, Duda, Angelika, Mirbach, Laura, Costina, Victor, Martens, Uwe M., Hofheinz, Ralf‐Dieter, Neumaier, Michael, Haselmann, Verena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120900/
https://www.ncbi.nlm.nih.gov/pubmed/34873826
http://dx.doi.org/10.1002/1878-0261.13156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120900/
https://www.ncbi.nlm.nih.gov/pubmed/34873826
http://dx.doi.org/10.1002/1878-0261.13156

Ejemplares similares